OpportunityAnalyzer: Axial Spondyloarthritis-Opportunity Analysis and Forecast to 2024

1
OpportunityAnalyzer Axial Spondyloarthritis-Oppor
tunity Analysis and Forecast to 2024
Single User License - 9495 Site User License -
18990 Corporate User License -
28485 Publication Date - Jun 2015 Pages -
187 To know more details, email to
debora_at_reportstack.com
2
Summary

• Ankylosing Spondylitis (AS) is an autoimmune
  disease that causes inflammation of the
  sacroiliac joint accompanied by pain and
  stiffness of the lower back, which typically gets
  better with exercise. Ankylosis (fusion) of the
  spine is typically a late-stage complication and
  has been nicknamed bamboo spine, due to its
  appearance on X-ray. It is now recognized that
  the pathological changes leading to ankylosis
  develop over time, and an early stage of the
  disease, known as non-radiographic axial
  spondyloarthritis (nr-axSpA) is characterized by
  the same symptoms of inflammatory back pain
  without radiographic changes observed by X-ray.
  Together, AS and nr-axSpA are known as axial
  spondyloarthritis (axSpA).

3
Key Findings

• Increased diagnosis and treatment are key drivers
  in the axSpA market.
• Novartiss Cosentyx will address the unmet need
  for drugs with novel MOAs and pose a threat to
  anti-TNFs, which are currently the only
  therapeutic class beyond NSAIDs.
• Label expansions into AS and nr-axSpA are
  expected to be an increasingly popular life-cycle
  management strategy for pharmaceutical companies
  developing drugs that target the immune system.
• Biosimilars are expected to change the landscape
  for axSpA and will create pricing pressure in the
  market.

4
Key Benefits

• Develop and design your in-licensing and
  out-licensing strategies through a review of
  pipeline products and technologies, and by
  identifying the companies with the most robust
  pipeline.
• Develop business strategies by understanding the
  trends shaping and driving the axSpA market.
• Drive revenues by understanding the key trends,
  innovative products and technologies, market
  segments, and companies likely to impact the
  global axSpA market in the future.
• Formulate effective sales and marketing
  strategies by understanding the competitive
  landscape and by analyzing the performance of
  various competitors.

5
Companies Mentioned
AbbViePfizerAmgenJohnson JohnsonMerckUCBN
ovartisCelgeneTakedaMitsubishi Tanabe
6
If you are interested...
Contact Debora White Email
debora_at_reportstack.com Ph1-888-789-6604 http/
/www.reportstack.com